How logistics failures put global health at risk

From famine-preventing foodstuffs to life-saving medicines, attention in times of crisis usually focuses on the production, pricing and procurement of essential commodities. But affordability at the point of purchase is not the same as access at the point of care: for the patient waiting at a clinic, a medicine, vaccine or therapeutic food that arrives too late is not available at all.

A recent heartbreaking report from Somalia illustrated this dilemma very well. “Skin and bones” is how Somalian mother Muumino Adan Aamin described her 11-month-old daughter, Ruweido, who for months had relied on daily sachets of Ready-to-Use Therapeutic Food, or RUTF – the peanut paste used to treat severe acute malnutrition. Such treatment existed in the supply chain, but when the mother went to a clinic in Baidoa, Somalia, she was repeatedly turned away because the clinic lacked supply.

The International Rescue Committee reported that an RUTF shipment enough to feed more than 1,000 children became stuck at an Indian port congested by cargo diverted from Gulf routes due to the war involving Iran. This is how supply-chain disruption often becomes a public-health emergency: because substances that in fact do exist cannot reach where they are desperately needed.

How a new logistics facility would keep health supplies moving

The world urgently needs a Humanitarian Logistics Shock Facility, a pre-funded mechanism to keep life-saving goods moving when normal routes break down.

Over the past 2 decades, global health institutions have helped make vaccines, medicines and diagnostics more affordable for millions. But much of this architecture was built around one central problem: how to develop, finance and procure products, not how to protect their journey through crisis, and that’s where such a new facility would make a huge difference.

Such a body would use pre-committed funds for emergency freight, fuel, cold-chain protection and last-mile delivery to clinics, camps and remote communities. It should release funds automatically when predefined shocks disrupt normal delivery – for example, a closed route, a sudden fuel-price surge, a blocked port or a climate event that makes ordinary access impossible. It could sit within, or alongside, an existing global health or humanitarian financing mechanism, with clear triggers and transparent rules.

Why global health lacks protection from logistics shocks

The vaccine alliance Gavi’s pneumococcal Advance Market Commitment showed what pooled financing can do when the world shapes a market around a public-health need. But there is no comparable shock absorber for logistics costs when routes collapse. When conflict forces ships onto longer journeys, freight and insurance costs can rise overnight. Humanitarian agencies and health ministries must absorb the difference and decide what will not be delivered.

In addition to such a new Humanitarian Logistics Shock Facility, other donor-funded programmes should follow the same logic: they should be judged not only by how cheaply they buy products, but by whether those products can still move when the usual route, fuel supply or supplier fails. Regional manufacturing also matters, but manufacturing resilience without logistics resilience will still leave patients exposed.

Global examples of health supply-chain disruption

Beyond Somalia, other examples abound of how such a new logistics Facility could save lives. Floods, inflation and import restrictions have left hospitals in Pakistan short of medicines. In Myanmar, conflict and transport disruption have interrupted tuberculosis and HIV treatment. In island communities in Indonesia and the Philippines, rising fuel costs can make the last mile the first service to be cut. India’s Covid oxygen crisis showed the same lesson at national scale: supplies existed, but hospitals could not reliably get them under pressure. 

Geopolitical instability is usually discussed in the language of markets and shipping: oil becomes more expensive even as journeys grow longer, and risk raises the cost of moving goods. But the shock does not stop at ports or balance sheets. It reaches a clinic when a tuberculosis patient misses treatment because the drugs have not arrived. It reaches a camp when oxygen is rationed. It reaches a vaccination team when supplies fail to appear. And it reaches a maternity ward when a delayed C-section turns a preventable complication into a death.

Why efficiency alone won’t protect health supply chains 

Fragility is built into the system: many health supply chains have been designed around a narrow idea of efficiency, where success means keeping stocks low and costs down. In normal times, spare capacity can look wasteful. In a crisis, it is the margin that determines whether medicines arrive or shelves go bare. For low-income and crisis-affected countries, that margin is often thinner still. A cholera kit can arrive after an outbreak has peaked. Vaccines can remain trapped in a container while children remain unprotected. Cold-chain-dependent supplies can spoil because the generator keeping them viable runs out of diesel.

When health supply chains break, the costs are measured not in delayed deliveries but in illness and preventable death. Disruptions are no longer exceptional. The real question is who absorbs the cost: a well-financed global shock facility, or a malnourished child waiting for therapeutic food that arrives too late.